Despite decades of experimentation, there have not been large increases in health care quality in the United States. What will move the needle?
Despite decades of experimentation, there have not been large increases in health care quality in the United States. What will move the needle?
In this week’s Managed Care Cast, Elizabeth McGlynn, PhD, speaks with Patricia Salber, MD, MBA, of The Doctor Weighs In, about health care quality in the United States, quality measurement and incentives, what the United States can do to drive quality improvement, how social determinants fit into the picture, and more.
McGlynn serves as Kaiser Permanente Bernard J. Tyson School of Medicine’s Interim Senior Associate Dean for Research and Scholarships and as a professor. She is an internationally known expert on methods for evaluating the appropriateness and quality of health care delivery.
Listen above or through one of these podcast services:
Read more about health care quality in the United States:
Can Healthcare Quality Measures Benefit Patient Health?
Dr Kerin Adelson Discusses Evolution in Physician Response to Quality Care Initiatives
Can Accountable Care Divert the Sources of Hospitalization?
Healthcare Needs Bipartisan Support to Benefit Patients, Stabenow Says
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More